Related Experiment Video

Updated: Aug 11, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Incidence of childhood precursor B-cell acute lymphoblastic leukaemia in north-west England

R J McNally, J M Birch, G M Taylor

    Lancet (London, England)
    |September 12, 2000
    PubMed

    Insights

    Childhood acute lymphoblastic leukaemia (ALL) incidence is rising in the UK, primarily due to an increase in the precursor B-cell subtype. This trend, observed between 1980-1998, suggests a potential link to infections.

    Area of Science:

    • Paediatric Oncology
    • Epidemiology
    • Immunology

    Background:

    • A notable temporal increase in childhood acute lymphoblastic leukaemia (ALL) incidence has been observed in the United Kingdom.
    • Data from the Manchester Children's Tumour Registry indicate this rise is linked to the precursor B-cell subtype of ALL.

    Discussion:

    • The childhood peak incidence (ages 1-4 years) showed a significant annual increase of 3.0% in precursor B-cell ALL from 1980 to 1998 (p=0.024).
    • Current research findings align with the hypothesis implicating infections as a causal factor in the development of precursor B-cell ALL.

    Key Insights:

    • The study provides strong evidence for an increasing trend in precursor B-cell ALL within the UK childhood population.
    • The observed epidemiological pattern supports the role of infectious agents in the aetiology of this specific leukaemia subtype.

    Outlook:

    • Further research is warranted to elucidate the specific infectious agents and mechanisms involved in precursor B-cell ALL.
    • Understanding these links may inform future prevention and treatment strategies for childhood leukaemia.

    More Related Videos

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells06:32

    A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells

    Published on: June 26, 2026

    Related Concept Videos

    Disorders of Leukocytes01:27

    Disorders of Leukocytes

    Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
    Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
    Cells of the Adaptive Immune Response01:23

    Cells of the Adaptive Immune Response

    The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...